Polar Capital’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-100,000
Closed -$819K 248
2017
Q3
$819K Buy
+100,000
New +$819K 0.01% 234
2016
Q4
Sell
-60,000
Closed -$423K 252
2016
Q3
$423K Buy
60,000
+10,000
+20% +$70.5K 0.01% 242
2016
Q2
$408K Hold
50,000
0.01% 253
2016
Q1
$407K Buy
+50,000
New +$407K 0.01% 254